Yekaterina Chudnovsky

Director/Board Member bei ELICIO THERAPEUTICS, INC.

Vermögen: 10 Mio $ am 31.03.2024

39 Jahre

Health Technology

Consumer Services

Technology Services

Aktive Positionen von Yekaterina Chudnovsky

Unternehmen	Position	Beginn	Ende
ELICIO THERAPEUTICS, INC.	Director/Board Member	01.10.2022	-
ELICIO THERAPEUTICS, INC.	Independent Dir/Board Member	01.10.2022	-
IMMIX BIOPHARMA, INC.	Director/Board Member	22.08.2023	-
IMMIX BIOPHARMA, INC.	Independent Dir/Board Member	22.08.2023	-
Elicio Therapeutics, Inc. (Old) Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA.	Director/Board Member	-	-
xCures, Inc. xCures, Inc. Packaged SoftwareTechnology Services xCures, Inc. engages in the development of artificial intelligence (AI) based precision oncology platform. It offers patients and physicians an individualized treatment options and facilitates access via reimbursement, clinical trials, and access support. The company was founded by Jeff Shrager and Jay Marty Tenenbaum in 2018 and is headquartered in Los Altos, CA.	Director/Board Member	-	-
Gkcc LLC	Director/Board Member	-	-

Northwestern University	Undergraduate Degree
DePaul University	Graduate Degree

International

Vereinigte Staaten

Operativ

Director/Board Member	5
Independent Dir/Board Member	2
Undergraduate Degree	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
IMMIX BIOPHARMA, INC.	Health Technology
ELICIO THERAPEUTICS, INC.	Health Technology

Private Unternehmen	3
Elicio Therapeutics, Inc. (Old) Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA.	Health Technology
xCures, Inc. xCures, Inc. Packaged SoftwareTechnology Services xCures, Inc. engages in the development of artificial intelligence (AI) based precision oncology platform. It offers patients and physicians an individualized treatment options and facilitates access via reimbursement, clinical trials, and access support. The company was founded by Jeff Shrager and Jay Marty Tenenbaum in 2018 and is headquartered in Los Altos, CA.	Technology Services
Gkcc LLC